Search Browse Earnings

Senti Biosciences, Inc. — SlamSEC

Senti Biosciences, Inc.

Nasdaq:SNTI

Biological Products, (No Diagnostic Substances)·SOUTH SAN FRANCISCO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$2.0M

-39.8% YoY

FY 2024

Adj. EBITDA

-$89.2M

-4507.9% margin

FY 2024

Net Income

-$71.1M

-3592.4% margin

FY 2024

EPS (Diluted)

-$16.01

FY 2024

Stock Price

$0.98

+2.8%

2026-03-09

52W Range

$0.80 – $5.10

P/E Ratio

-0.1x

Market Cap

$25.8M

Cash

$35.9M

FY 2024

Total Debt

—

Net Cash

$35.9M

FY 2024

Enterprise Value

-$10.1M

Debt / EBITDA

0.4x

FY 2024

EV / EBITDA

0.1x

Employees

—

CEO

Lu Timothy K